HWM
GILD icon

Hemington Wealth Management’s Gilead Sciences GILD Stock Holding History

Hemington Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$110K Buy
998
+85
+9% +$9.66K 0.01% 223
2025
Q2 		$101K Buy
913
+85
+10% +$9.05K 0.01% 215
2025
Q1 		$92K Buy
828
+155
+23% +$16K 0.01% 219
2024
Q4 		$62K Buy
673
+149
+28% +$13.4K 0.02% 271
2024
Q3 		$46K Buy
+524
New +$40K 0.01% 309

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Hemington Wealth Management's GILD Position: Q3 2025 in Review

Hemington Wealth Management increased its Gilead Sciences (GILD) stake by 9.3% in Q3 2025, buying an estimated $9.66K and bringing the position to 998 shares worth $110K. The position accounts for 0.01% of the portfolio, ranked #223.

Hemington Wealth Management first reported a position in GILD in Q3 2024 and has held it in 5 quarters since. 2,026 funds tracked by Wall St. Rank hold GILD as of Q3 2025.

  • Hemington Wealth Management held 998 shares of Gilead Sciences worth $110K as of Q3 2025.
  • Hemington Wealth Management bought 85 Gilead Sciences shares in Q3 2025, an estimated $9.66K.
  • Gilead Sciences made up 0.01% of Hemington Wealth Management's portfolio in Q3 2025, its #223 holding.
  • Hemington Wealth Management first reported a position in Gilead Sciences in Q3 2024 and has held it in 5 quarters since.
  • 2,026 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2025.

Based on Hemington Wealth Management's 13F filing for Q3 2025, filed 24 Oct 2025.